Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated

DB15484ApprovedInvestigationalVaccines

Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated: Overview.

First approval
Canada, 2010 · European Union, 2022
Brand names
  • Dukoral

What you can answer from here — as of April 21, 2026

9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
10Marketed productsAcross 6 countries and 4 labellers
Sign in

Which other approved drugs treat the same conditions as Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In